Ozempic maker Novo Nordisk spent $11 million last year on medical “wine and dining.” Experts are calling the move a breach of doctor-patient trust
Experts are sounding the alarm after a report that popular weight-loss injectable maker Novo Nordisk spent $11 million last year on meals and travel for thousands of prescribers. Photo by …